WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 574740
Description: Ibandronic Acid is a bisphosphonate anti-resorptive agent and bone resorption inhibitor.
MedKoo Cat#: 574740
Name: Ibandronic Acid
Chemical Formula: C9H23NO7P2
Exact Mass: 319.095
Molecular Weight: 319.23
Elemental Analysis: C, 33.86; H, 7.26; N, 4.39; O, 35.08; P, 19.41
Ibandronic Acid, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.
Synonym: Ibandronic Acid; BPH 24; Ibandronate
IUPAC/Chemical Name: P,P'-[1-Hydroxy-3-(methylpentylamino)propylidene]bisphosphonic Acid
InChi Key: MPBVHIBUJCELCL-UHFFFAOYSA-N
InChi Code: InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)
SMILES Code: CCCCCN(CCC(P(O)(O)=O)(P(O)(O)=O)O)C
The following data is based on the product molecular weight 319.23 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. McCormack PL, Plosker GL. Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer. Drugs. 2006;66(5):711-728. doi:10.2165/00003495-200666050-00011
2. Barrett-Lee P, Casbard A, Abraham J, et al. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial [published correction appears in Lancet Oncol. 2014 Feb;15(2):e52-3]. Lancet Oncol. 2014;15(1):114-122. doi:10.1016/S1470-2045(13)70539-4